Find participating medical centers and current study status in each of them

    Find participating medical centers

    Clinical trial of atezolizumab plus chemotherapy compared with chemotherapy alone for patients with recurrent triple-negative breast cancer (IMpassion132)

    A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer (IMpassion132)

    • Cancer
    • Breast Cancer
    • Triple Negative Breast Neoplasms
    • Triple Negative Breast Cancer